Identification and validation of alternative splicing isoforms as novel biomarker candidates in hepatocellular carcinoma

Wu,Peng; Zhou,Donghu; Wang,Yuqian; Lin,Weiran; Sun,Aihua; Wei,Handong; Fang,Yi; Cong,Xianling; Jiang,Ying

doi:10.3892/or.2018.6947

Identification and validation of alternative splicing isoforms as novel biomarker candidates in hepatocellular carcinoma

Authors:
- Peng Wu
- Donghu Zhou
- Yuqian Wang
- Weiran Lin
- Aihua Sun
- Handong Wei
- Yi Fang
- Xianling Cong
- Ying Jiang
View Affiliations

Affiliations: State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, P.R. China, Department of Dermatology, China‑Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China, Department of Endocrinology, Beijing 307 Hospital, Beijing 100070, P.R. China
Published online on: December 21, 2018 https://doi.org/10.3892/or.2018.6947
Pages: 1929-1937

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Alternative splicing (AS) is a transcriptional regulation mechanism that participates in multiple aspects of cancer. The present study aimed to identify differential AS events from tumor and non‑tumor samples and investigate the potential of AS as a source of candidate cancer diagnostic biomarkers. Deep RNA sequencing of three paired hepatocellular carcinoma (HCC) tumors and adjacent non‑tumors was applied to identify AS events. RT‑qPCR was performed on 45 HCC clinical samples to validate the splicing differences. The maximal information coefficient was first used to build an association between clinical features and AS changes. We identified 197 significantly differential skipped exon events, of which only 29% overlapped with the differentially expressed genes. The differentially spliced genes were mainly enriched in HCC‑characterized biological processes and pathways, clearly separating tumors from non‑tumors. We also validated the statistically significant splicing differences of three AS candidates (CEACAM1 exon 7, VPS29 exon 2 and ISOC2 exon 3). Furthermore, a clinicopathological analysis revealed that carcinoembryonic antigen‑related cell adhesion molecule 1 (CEACAM1) exon 7 was significantly correlated with the survival time, and VPS29 exon 2 was associated with cell differentiation stages. In conclusion, the findings of the three AS candidates in the present study could be beneficial in HCC prognosis and new treatment strategies.

View Figures

View References

1	Lou J, Zhang L, Lv S, Zhang C and Jiang S: Biomarkers for hepatocellular carcinoma. Biomark Cancer. 9:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
2	Burkhart RA, Ronnekleiv-Kelly SM and Pawlik TM: Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response. Surg Oncol. 26:138–145. 2017. View Article : Google Scholar : PubMed/NCBI
3	Luz FA, Brigido PC, Moraes AS and Silva MJ: Aberrant splicing in cancer: Mediators of malignant progression through an imperfect splice program shift. Oncology. 92:3–13. 2017. View Article : Google Scholar : PubMed/NCBI
4	Ding C, Li Y, Guo F, Jiang Y, Ying W, Li D, Yang D, Xia X, Liu W, Zhao Y, et al: A cell-type-resolved liver proteome. Mol Cell Proteomics. 15:3190–3202. 2016. View Article : Google Scholar : PubMed/NCBI
5	Merkin J, Russell C, Chen P and Burge CB: Evolutionary dynamics of gene and isoform regulation in Mammalian tissues. Science. 338:1593–1599. 2012. View Article : Google Scholar : PubMed/NCBI
6	Zhang J and Manley JL: Misregulation of pre-mRNA alternative splicing in cancer. Cancer Discov. 3:1228–1237. 2013. View Article : Google Scholar : PubMed/NCBI
7	Villegas-Ruiz V, Hendlmeier F, Buentello-Volante B, Rodriguez-Loaiza JL, Miranda-Duarte A and Zenteno JC: Genome-wide mRNA analysis reveals a TUBD1 isoform profile as a potential biomarker for diabetic retinopathy development. Exp Eye Res. 155:99–106. 2017. View Article : Google Scholar : PubMed/NCBI
8	Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z and He J: Prognostic alternative mRNA splicing signature in non-small cell lung cancer. Cancer Lett. 393:40–51. 2017. View Article : Google Scholar : PubMed/NCBI
9	Singh B and Eyras E: The role of alternative splicing in cancer. Transcription. 8:91–98. 2017. View Article : Google Scholar : PubMed/NCBI
10	He C, Zhou F, Zuo Z, Cheng H and Zhou R: A global view of cancer-specific transcript variants by subtractive transcriptome-wide analysis. PLoS One. 4:e47322009. View Article : Google Scholar : PubMed/NCBI
11	Laversin SA, Phatak VM, Powe DG, Li G, Miles AK, Hughes DC, Ball GR, Ellis IO, Gritzapis AD, Missitzis I, et al: Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cells. Genes Chromosomes Cancer. 52:316–329. 2013. View Article : Google Scholar : PubMed/NCBI
12	Wang X, Sheng P, Guo X, Wang J, Hou L, Hu G, Luo C, Dong Y and Lu Y: Identification and expression of a novel MDM4 splice variant in human glioma. Brain Res 1537. 260–266. 2013.
13	Arafat H, Lazar M, Salem K, Chipitsyna G, Gong Q, Pan TC, Zhang RZ, Yeo CJ and Chu ML: Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer. Surgery. 150:306–315. 2011. View Article : Google Scholar : PubMed/NCBI
14	Kim YJ and Kim HS: Alternative splicing and its impact as a cancer diagnostic marker. Genomics Inform. 10:74–80. 2012. View Article : Google Scholar : PubMed/NCBI
15	Lin KT, Shann YJ, Chau GY, Hsu CN and Huang CY: Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing. Oncogene. 33:4786–4794. 2014. View Article : Google Scholar : PubMed/NCBI
16	Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong KJ, Liu M, Song Y, Chow RK, Ng VH, et al: A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut. 63:832–843. 2014. View Article : Google Scholar : PubMed/NCBI
17	Trapnell C, Pachter L and Salzberg SL: TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics. 25:1105–1111. 2009. View Article : Google Scholar : PubMed/NCBI
18	Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL and Pachter L: Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 7:562–578. 2012. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Reshef DN, Reshef YA, Finucane HK, Grossman SR, McVean G, Turnbaugh PJ, Lander ES, Mitzenmacher M and Sabeti PC: Detecting novel associations in large data sets. Science. 334:1518–1524. 2011. View Article : Google Scholar : PubMed/NCBI
21	Thorvaldsdottir H, Robinson JT and Mesirov JP: Integrative genomics viewer (IGV): High-performance genomics data visualization and exploration. Brief Bioinform. 14:178–192. 2013. View Article : Google Scholar : PubMed/NCBI
22	Yu G, Wang LG, Han Y and He QY: ClusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
23	Shen S, Park JW, Huang J, Dittmar KA, Lu ZX, Zhou Q, Carstens RP and Xing Y: MATS: A Bayesian framework for flexible detection of differential alternative splicing from RNA-Seq data. Nucleic Acids Res. 40:e612012. View Article : Google Scholar : PubMed/NCBI
24	Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN, Zhou Q and Xing Y: rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci USA. 111:E5593–E5601. 2014. View Article : Google Scholar : PubMed/NCBI
25	Chen Z, Chen L, Qiao SW, Nagaishi T and Blumberg RS: Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70. J Immunol. 180:6085–6093. 2008. View Article : Google Scholar : PubMed/NCBI
26	Le KQ, Prabhakar BS, Hong WJ and Li LC: Alternative splicing as a biomarker and potential target for drug discovery. Acta Pharmacol Sin. 36:1212–1218. 2015. View Article : Google Scholar : PubMed/NCBI
27	Wojtuszkiewicz A, Assaraf YG, Maas MJ, Kaspers GJ, Jansen G and Cloos J: Pre-mRNA splicing in cancer: The relevance in oncogenesis, treatment and drug resistance. Expert Opin Drug Metab Toxicol. 11:673–689. 2015. View Article : Google Scholar : PubMed/NCBI
28	Williams AF and Barclay AN: The immunoglobulin superfamily-domains for cell surface recognition. Annu Rev Immunol. 6:381–405. 1988. View Article : Google Scholar : PubMed/NCBI
29	Cruz PV, Wakai T, Shirai Y, Yokoyama N and Hatakeyama K: Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression is an adverse prognostic factor in hepatocellular carcinoma. Cancer. 104:354–360. 2005. View Article : Google Scholar : PubMed/NCBI
30	Kiriyama S, Yokoyama S, Ueno M, Hayami S, Ieda J, Yamamoto N, Yamaguchi S, Mitani Y, Nakamura Y, Tani M, et al: CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma. Ann Surg Oncol. 21 Suppl 4:S505–S514. 2014. View Article : Google Scholar : PubMed/NCBI
31	Lawson EL, Mills DR, Brilliant KE and Hixson DC: The transmembrane domain of CEACAM1-4S is a determinant of anchorage independent growth and tumorigenicity. PLoS One. 7:e296062012. View Article : Google Scholar : PubMed/NCBI
32	Zhu J, Yang Y, Ma C, Zhang G, Wang K and Hu S: CEACAM1 cytoplastic expression is closely related to tumor angiogenesis and poorer relapse-free survival after curative resection of hepatocellular carcinoma. World J Surg. 35:2259–2265. 2011. View Article : Google Scholar : PubMed/NCBI
33	Kobel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, et al: Ovarian carcinoma subtypes are different diseases: Implications for biomarker studies. PLoS Med. 5:e2322008. View Article : Google Scholar : PubMed/NCBI
34	Viasus D, Del Rio-Pertuz G, Simonetti AF, Garcia-Vidal C, Acosta-Reyes J, Garavito A and Carratalà J: Biomarkers for predicting short-term mortality in community-acquired pneumonia: A systematic review and meta-analysis. J Infect. 72:273–282. 2016. View Article : Google Scholar : PubMed/NCBI